Company
About us
History
Leaderships
Team
EU grants
Requests for Proposal
Sustainability – ESG
Bussines strategy
Quality policy
Virtual Tour
Investors
Corporate documents
Shareholders and shares
Periodic reports
Current reports
Sustainability reports
Corporate governance at Mabion
Financial data
For Investors
Calendar
Resources
Science Hub
Press releases
News
Events
Media kit
Services
Process Development
Analytics
Drug Substance Manufacturing
Contact
Contact form
Contact for investors
Contact for media
Careers
Science News
Resources
Manufacturing
Time to Market Strategy – 5 CDMO Tactics to Speed Up Biologic Launches
Biologics
,
Drug development
,
Manufacturing
Navigating OOX Results: Effective Analysis and Management in CDMO Laboratories
Analytics
,
Manufacturing
,
Regulatory
Mammalian Cell Lines as a Platform for Protein Vaccine Production
Cell culture
,
Drug substance
,
Manufacturing
,
Proteins
,
Vaccines
CHO Cell Lines for Recombinant Protein Production
Drug development
,
Drug product
,
Manufacturing
Leading European CDMO for Drug Product Manufacturing
Drug development
,
Drug product
,
Manufacturing
Antibodies Development Best Practices for CDMO Collaboration
Drug development
,
Manufacturing
,
Monoclonal antibody
Biologics CDMO Solutions for the Future of Therapeutics
Biologics
,
Drug development
,
Manufacturing
Bioprocess Operation Modes and Advanced Bioreactor Technology
Cell culture
,
Drug substance
,
Manufacturing
Ion Exchange Chromatography in Monoclonal Antibodies Purification
Analytics
,
Manufacturing
Previous
1
2
3
4
Next